TD Asset Management
ONC

TD Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

TD Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.97M Sell
10,014
-5,738
-36% -$1.86M ﹤0.01% 885
2025
Q4 		$4.79M Sell
15,752
-11,625
-42% -$3.81M ﹤0.01% 808
2025
Q3 		$9.33M Buy
+27,377
New +$8.31M 0.01% 673
2025
Q2 		– Sell
-116,104
Closed -$31.6M – 1269
2025
Q1 		$31.6M Sell
116,104
-7,491
-6% -$1.75M 0.03% 405
2024
Q4 		$22.8M Sell
123,595
-1,817
-1% -$371K 0.02% 487
2024
Q3 		$27.4M Buy
125,412
+11,034
+10% +$1.99M 0.02% 435
2024
Q2 		$16.3M Buy
114,378
+1,599
+1% +$246K 0.02% 533
2024
Q1 		$17.6M Buy
112,779
+11,116
+11% +$1.79M 0.02% 516
2023
Q4 		$18.3M Buy
101,663
+1,407
+1% +$255K 0.02% 497
2023
Q3 		$18M Buy
100,256
+48,018
+92% +$9.5M 0.02% 445
2023
Q2 		$9.31M Buy
52,238
+17,555
+51% +$4.04M 0.01% 612
2023
Q1 		$7.48M Buy
34,683
+16,748
+93% +$4.02M 0.01% 661
2022
Q4 		$3.94M Buy
17,935
+954
+6% +$175K ﹤0.01% 799
2022
Q3 		$2.31M Sell
16,981
-1,339
-7% -$230K ﹤0.01% 959
2022
Q2 		$2.96M Sell
18,320
-5,645
-24% -$882K ﹤0.01% 885
2022
Q1 		$4.52M Sell
23,965
-561
-2% -$119K ﹤0.01% 845
2021
Q4 		$6.64M Buy
24,526
+93
+0.4% +$31.4K 0.01% 794
2021
Q3 		$8.87M Buy
24,433
+97
+0.4% +$31.7K 0.01% 678
2021
Q2 		$7.7M Sell
24,336
-5,017
-17% -$1.66M 0.01% 721
2021
Q1 		$10.2M Buy
29,353
+1,061
+4% +$351K 0.01% 632
2020
Q4 		$7.31M Sell
28,292
-6,893
-20% -$1.9M 0.01% 688
2020
Q3 		$10.1M Buy
35,185
+8,534
+32% +$2.01M 0.01% 541
2020
Q2 		$5.02M Buy
26,651
+2,600
+11% +$423K 0.01% 658
2020
Q1 		$2.96M Sell
24,051
-1,100
-4% -$172K 0.01% 739
2019
Q4 		$4.17M Sell
25,151
-3,585
-12% -$596K 0.01% 755
2019
Q3 		$3.52M Sell
28,736
-2,400
-8% -$319K 0.01% 767
2019
Q2 		$3.86M Buy
31,136
+888
+3% +$113K 0.01% 746
2019
Q1 		$3.99M Buy
30,248
+400
+1% +$54K 0.01% 753
2018
Q4 		$4.18M Buy
29,848
+3,200
+12% +$424K 0.01% 714
2018
Q3 		$4.59M Sell
26,648
-1,700
-6% -$286K 0.01% 756
2018
Q2 		$4.36M Buy
28,348
+800
+3% +$143K 0.01% 753
2018
Q1 		$4.63M Buy
27,548
+5,780
+27% +$783K 0.01% 692
2017
Q4 		$2.13M Sell
21,768
-1,800
-8% -$165K ﹤0.01% 870
2017
Q3 		$2.44M Buy
23,568
+800
+4% +$59.6K ﹤0.01% 824
2017
Q2 		$1.02M Sell
22,768
-3,900
-15% -$154K ﹤0.01% 1036
2017
Q1 		$976K Sell
26,668
-1,300
-5% -$47.4K ﹤0.01% 1044
2016
Q4 		$849K Buy
27,968
+2,912
+12% +$91.5K ﹤0.01% 1051
2016
Q3 		$772K Sell
25,056
-177,564
-88% -$5.16M ﹤0.01% 1066
2016
Q2 		$725K Hold
202,620
– – ﹤0.01% 1021
2016
Q1 		$713K Buy
+202,620
New +$5.74M ﹤0.01% 1035

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TD Asset Management's ONC Position: Q1 2026 in Review

TD Asset Management reduced its BeOne Medicines Ltd (ONC) stake by 36% in Q1 2026, selling an estimated $1.86M and leaving 10,014 shares worth $2.97M. The position accounts for ﹤0.01% of the portfolio, ranked #885.

TD Asset Management first reported a position in ONC in Q1 2016 and has held it in 40 quarters since. The position peaked at $31.6M in Q1 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • TD Asset Management held 10,014 shares of BeOne Medicines Ltd worth $2.97M as of Q1 2026.
  • TD Asset Management sold 5,738 BeOne Medicines Ltd shares in Q1 2026, an estimated $1.86M.
  • BeOne Medicines Ltd made up ﹤0.01% of TD Asset Management's portfolio in Q1 2026, its #885 holding.
  • TD Asset Management first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 40 quarters since.
  • TD Asset Management's BeOne Medicines Ltd position peaked at $31.6M in Q1 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.